Mitsutaka Kino

Title: Mitsutaka Kino: Innovator in Reduced Glutathione Production

Introduction

Mitsutaka Kino is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the production of reduced glutathione. With a total of 2 patents to his name, his work has implications for various applications in health and industry.

Latest Patents

Kino's latest patents focus on innovative methods for manufacturing reduced glutathione. The first patent describes a method for producing reduced glutathione through the electrolytic reduction of oxidized glutathione. This process utilizes a cathode cell and an anode cell that are separated by a membrane. The cathode features a metal surface, and the cathode solution is an aqueous oxidized glutathione solution with a pH adjusted between 3.0 and 5.0 by adding a base. The base is composed of the same metal as the cathode surface, a metal salt, or a metal oxide.

The second patent outlines a process for producing reduced glutathione by electroreduction of oxidized glutathione. This method also employs a cathode cell and an anode cell separated by a membrane. The solution in the cathode cell is an aqueous oxidized glutathione solution with a pH adjusted to be higher than 3.0 and not more than 7.0 by adding a base. In this process, oxidized glutathione itself acts as a conducting agent.

Career Highlights

Mitsutaka Kino is currently associated with Kyowa Hakko Bio Co., Ltd., a company known for its advancements in biotechnology. His work at the company has allowed him to focus on innovative solutions in the production of biochemicals.

Collaborations

Kino collaborates with talented individuals such as Kenta Fukumoto and Miyuki Fukuda. Their combined expertise contributes to the success of their projects and the advancement of their research.

Conclusion

Mitsutaka Kino's contributions to the field of reduced glutathione production highlight his innovative spirit and dedication to biochemistry. His patents reflect a commitment to advancing methods that can have a significant impact on health and industry.